|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| C12Q 1/6886 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3589747 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17711365.1 |
| Europos patento paraiškos padavimo data | 2017-03-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-01-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2017/008206 |
| Data | 2017-03-01 |
| (87) | Numeris | WO 2018/158898 |
| Data | 2018-09-07 |
| (72) |
OHASHI, Akihiro, JP
IWAI, Kenichi, JP
NAMBU, Tadahiro, JP
DAIRIKI, Ryo, JP
ISHII, Yuko, US
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
|
| (54) | METHOD OF PREDICTING EFFECTS OF CDC7 INHIBITOR |
| METHOD OF PREDICTING EFFECTS OF CDC7 INHIBITOR |